Table 3.
Dietary intake g/day·MJ | Positive psychotic-like symptoms a | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Median | Interquintile range | Low level group | Middle level group | High level group | |||||||||
Energy adjusted | Multivariateb | Energy adjusted | Multivariateb | ||||||||||
Marine fatty acidsc | No. | No. | RR | 95% CI | RR | 95% CI | No. | RR | 95% CI | RR | 95% CI | ||
0.016 | (0.00-0.02) | 4478 | Ref. | 3637 | 237 | ||||||||
0.030 | (0.02-0.04) | 4606 | 3587 | 0.94 | 0.89-1.00 | 0.97 d | 0.91-1.03 | 177 | 0.71 | 0.58-0.87 | 0.75 d | 0.61-0.92 | |
0.050 | (0.04-0.06) | 4733 | 3538 | 0.91 | 0.86-0.97 | 0.96 d | 0.90-1.02 | 176 | 0.69 | 0.57-0.85 | 0.76 d | 0.61-0.93 | |
0.070 | (0.06-0.80) | 4594 | 3633 | 1.00 | 0.94-1.06 | 1.05 d | 0.98-1.13 | 227 | 0.96 | 0.80-1.16 | 1.05 d | 0.85-1.29 | |
Omega-6 fatty acidse | |||||||||||||
0.6 | (0.1-0.7) | 4408 | Ref. | 3712 | 261 | ||||||||
0.7 | (0.6-0.8) | 4709 | 3513 | 0.88 | 0.82-0.93 | 0.88 f | 0.83-0.94 | 182 | 0.64 | 0.53-0.78 | 0.67 f | 0.55-0.82 | |
0.8 | (0.7-0.8) | 4670 | 3582 | 0.90 | 0.85-0.96 | 0.91 f | 0.86-0.97 | 173 | 0.62 | 0.51-0.75 | 0.66 f | 0.54-0.81 | |
0.9 | (0.9-2.1) | 4624 | 3588 | 0.92 | 0.86-0.98 | 0.93 f | 0.86-0.99 | 201 | 0.73 | 0.60-0.88 | 0.78 f | 0.64-0.97 | |
Omega-3 fatty acidsg | |||||||||||||
0.14 | (0.02-0.17) | 4444 | Ref. | 3663 | 252 | ||||||||
0.18 | (0.17-0.20) | 4613 | 3628 | 0.95 | 0.89-1.01 | 0.98 b | 0.92-1.04 | 175 | 0.66 | 0.54-0.81 | 0.73 h | 0.60-0.89 | |
0.21 | (0.20-0.22) | 4736 | 3512 | 0.90 | 0.84-0.96 | 0.95 b | 0.89-1.01 | 176 | 0.66 | 0.53-0.80 | 0.76 h | 0.62-0.94 | |
0.26 | (0.22-0.93) | 4618 | 3592 | 0.96 | 0.90-1.02 | 1.02 b | 0.95-1.09 | 214 | 0.83 | 0.69-1.00 | 1.00 h | 0.82-1.23 |
a Participants categorized into levels of psychotic-like symptoms; low, middle, high (see methods section)
b In the multivariate analysis presented, we initially tested the effects of adjusting also for BMI, level of education, country of birth, smoking, dietary intake of meat, dairy products, fruits, cereals and refined sugar, rheumatoid arthritis, gluten intolerance, diabetes and multivitamin supplement. However, none of these covariates change the estimates substantially, and was therefore not included in the final multivariate model
c Sum of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and docosapentaenoic acid
d Adjusted for age, total energy intake and dietary intake of vitamin B12, alcohol and dietary intake of fat other than eicosapentaenoic acid, docosahexaenoic acid and docosapentaenoic acid
e Sum of arachidonic and linoleic acids
f Adjusted for age, total energy intake and dietary intake of vitamin B12, alcohol and dietary intake of other than omega-6 fatty acids
g Sum of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), docosapentaenoic acid and α-linolenic acid
hAdjusted for age, total energy intake and dietary intake of vitamin B12, alcohol and dietary intake of other than omega-3 fatty acids